Clinical Characteristics of Patients with Advanced ALK-Translocated Non-small Cell Lung Cancers and Long-Term Responses to Crizotinib (CRIZOLONG GFPC 05-19 Study).
Auteurs : Dhamelincourt, E ; Descourt, R ; Rousseau-Bussac, G ; Doubre, H ; Decroisette, C ; Demontrond, P & al (Guisier F).
